.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Healthtrust
Federal Trade Commission
Citi
McKesson
Cipla
UBS
Deloitte
Express Scripts
Queensland Health

Generated: December 18, 2017

DrugPatentWatch Database Preview

Losartan potassium - Generic Drug Details

« Back to Dashboard

What are the generic sources for losartan potassium and what is the scope of losartan potassium freedom to operate?

Losartan potassium
is the generic ingredient in two branded drugs marketed by Merck Sharp Dohme, Alembic Pharms Ltd, Apotex Corp, Aurobindo Pharma, Cadista Pharms, Hetero Labs Ltd V, Ipca Labs Ltd, Lupin Ltd, Macleods Pharms Ltd, Mylan, Prinston Inc, Sandoz, Teva, Torrent Pharms, Unichem Labs Ltd, Upsher-smith Labs, Viva Hlthcare, Vivimed Global, Watson Labs, West-ward Pharms Int, and Zydus Pharms Usa Inc, and is included in twenty-one NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-seven drug master file entries for losartan potassium. Sixty-eight suppliers are listed for this compound.

Pharmacology for losartan potassium

Medical Subject Heading (MeSH) Categories for losartan potassium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Torrent PharmsLOSARTAN POTASSIUMlosartan potassiumTABLET;ORAL090467-002Oct 6, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
SandozLOSARTAN POTASSIUMlosartan potassiumTABLET;ORAL077424-003Oct 6, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Hetero Labs Ltd VLOSARTAN POTASSIUMlosartan potassiumTABLET;ORAL203835-003Aug 12, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Ipca Labs LtdLOSARTAN POTASSIUMlosartan potassiumTABLET;ORAL200290-002Aug 30, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
West-ward Pharms IntLOSARTAN POTASSIUMlosartan potassiumTABLET;ORAL077459-003Oct 6, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Upsher-smith LabsLOSARTAN POTASSIUMlosartan potassiumTABLET;ORAL090544-001Oct 6, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
MylanLOSARTAN POTASSIUMlosartan potassiumTABLET;ORAL091590-003Oct 6, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Aurobindo PharmaLOSARTAN POTASSIUMlosartan potassiumTABLET;ORAL090083-001Oct 6, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Viva HlthcareLOSARTAN POTASSIUMlosartan potassiumTABLET;ORAL091541-001Sep 24, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Vivimed GlobalLOSARTAN POTASSIUMlosartan potassiumTABLET;ORAL090382-003Oct 6, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: losartan potassium

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck Sharp DohmeCOZAARlosartan potassiumTABLET;ORAL020386-002Apr 14, 1995► Subscribe► Subscribe
Merck Sharp DohmeCOZAARlosartan potassiumTABLET;ORAL020386-003Oct 13, 1998► Subscribe► Subscribe
Merck Sharp DohmeCOZAARlosartan potassiumTABLET;ORAL020386-001Apr 14, 1995► Subscribe► Subscribe
Merck Sharp DohmeCOZAARlosartan potassiumTABLET;ORAL020386-002Apr 14, 1995► Subscribe► Subscribe
Merck Sharp DohmeCOZAARlosartan potassiumTABLET;ORAL020386-001Apr 14, 1995► Subscribe► Subscribe
Merck Sharp DohmeCOZAARlosartan potassiumTABLET;ORAL020386-003Oct 13, 1998► Subscribe► Subscribe
Merck Sharp DohmeCOZAARlosartan potassiumTABLET;ORAL020386-002Apr 14, 1995► Subscribe► Subscribe
Merck Sharp DohmeCOZAARlosartan potassiumTABLET;ORAL020386-003Oct 13, 1998► Subscribe► Subscribe
Merck Sharp DohmeCOZAARlosartan potassiumTABLET;ORAL020386-002Apr 14, 1995► Subscribe► Subscribe
Merck Sharp DohmeCOZAARlosartan potassiumTABLET;ORAL020386-001Apr 14, 1995► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Fish and Richardson
Teva
Mallinckrodt
Julphar
Daiichi Sankyo
McKesson
Healthtrust
Deloitte
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot